Global Hepatitis B Antiviral Drugs Market is poised for steady growth as the prevalence of hepatitis B rises globally and new antiviral treatments continue to emerge. Hepatitis B is a viral infection that attacks the liver, and antiviral drugs are vital for managing the disease. The global Hepatitis B antiviral drugs market is expected to grow from $5.22 billion USD in...